Observational study / 2018
Intragastric balloon hyperinsufflation can cause an acute obstructive abdomen, which resolves with balloon removal if irreversible ischemia is absent.
This case report highlights intragastric balloon (IGB) hyperinsufflation following FDA warnings regarding potential complications, including acute pancreatitis and balloon hyperinsufflation with the Orbera balloon for obesity treatment. Clinicians are alerted that hyperinsufflation should be considered in patients presenting with an IGB and an acute abdomen. Removal of the IGB resolves complaints if there is no irreversible ischemia of the stomach walls. Due to an increased risk of pulmonary aspiration during removal, endotracheal intubation is strongly recommended.
Shows an association, not proof of cause and effect.
- Study type
- Case report
- Who was studied
- Patient(s) with an intragastric balloon and acute abdomen
- What was measured
- Intragastric balloon hyperinsufflation and acute obstructive abdomen
THE PAPER
Intragastric Balloon Hyperinsufflation as a Cause of Acute Obstructive Abdomen.
de Quadros LG, Dos Passos Galvão Neto M, Grecco E, de Souza TF, Kaiser RL, Campos JM, Teixeira A, Filho AC, Macedo G, Silva M. ACG Case Rep J, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.